Stryker crushes Zimmer with $70M patent violation verdict
FierceMedicalDevice
BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts, and Glaucoma
Yahoo/MarketWire
Novartis Earnings: Patent Cliff Edition
The Motley Fool
India set to rule in Novartis patent case
FiercePharma
Tranzyme Partners with Bristol-Myers, Lilly Fights Patent Cliff: Healthcare Business Recap
Wall Street Cheat Sheet
Submitted by stengaard on Wed, 12/12/2012 - 09:01
Another door closes on Abbott
A new formidable market of +1,3 billion inhabitants is now open to BioPorto via the Chinese (PRC) issuing of the crucial cut-off patent (250 ng/ml – lest you’ve forgotten) – The patent protected blockbuster candidate -the NGAL Test now rules supreme in China – India, Europe (the EPO-area)- and South Africa and, and, and…
But even though India and other subcontinenents/areas/countries are important – China is, in this respect, the jewel in the crown. Oh – and then there is the long.-time pending Patent Applications in The US (USPTO) and Canada – but otherwise World Domination :)
Submitted by moderatorj on Mon, 11/26/2012 - 23:06
Illumina wins chance to battle Complete Genomics over patents
FierceMedicalDevice
Submitted by moderatorj on Wed, 11/21/2012 - 15:26
Cardium Therapeutics claims patent win over Boston Scientific
Submitted by moderatorj on Wed, 11/21/2012 - 15:16
Greatbatch awarded patent for Spacers for Fixing Battery Cells
Yahoo/TheFlyOnTheWall